3Hogan SP, Rosenberg HF, Moqbel R, et al. Eosinophils: biological properties and role in health and disease[J]. Clin Exp Allergy. 2008,38:709-750.
4Venge P. Monitoring the allergic inflammation[J]. Allergy. 2004,59:26-32.
5Wei W,Yu L,L tl H,et al. Comparison of cause distribution between elderly and non-elderly patients with chronic cough[J]. Respiration, 2009,77: 259-64.
6Nissly T, Prasad S. This asthma treatment has a lasting side effect in children[J]. J Fam Pract. 2013 Sep;62(9):500-2.
7Lee YJ, Lee HH, Choi BS, et al. Association between eosinophilic airway in- flammation and persistent airflow limitation[J]. J Asthma. 2013 , 50(4):342-6.
8Yeon-Joon Park, Eun-Jee Oh, Jong-Won Park, et al. Plasma Eosinophil Cationic Protein, Interleukin-5, and ECP/Eo Count Ratio in Patients with Vari- ous Eosinophilic Diseases[J]. Ann Clin Lab Sci,2006,36(3): 262-266.
9Y u ksel B, Aydemir C, Ust u ndag G,et al.The effect of lieatment with mon- telukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma [J]. Turk J Pediatr. 2009 , 51 (5):460-5.
